We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
-2.44%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
AUM
$308M
AUM Growth
-$109M
Cap. Flow
-$101M
Cap. Flow %
-32.88%
Top 10 Hldgs %
27.78%
Holding
155
New
31
Increased
75
Reduced
13
Closed
36

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$5.3M
2
DLTR icon
Dollar Tree
DLTR
+$5.02M
3
IMMR icon
Immersion
IMMR
+$4.97M
4
MCK icon
McKesson
MCK
+$4.21M
5
BPOP icon
Popular Inc
BPOP
+$3.58M

Sector Composition

Rank Sector Weight
1 Financials 14.96%
2 Consumer Discretionary 13.29%
3 Materials 11.69%
4 Industrials 11.21%
5 Healthcare 8.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORN icon
101
Orion Group Holdings
ORN
$402M
$573K 0.19%
105,198
+11,155
+12% +$61.1K
ZVO
102
DELISTED
Zovio Inc. Common Stock
ZVO
$563K 0.18%
235,424
+25,596
+12% +$63.2K
GAIA icon
103
Gaia
GAIA
$48.4M
$521K 0.17%
54,878
+29,012
+112% +$306K
GRPN icon
104
Groupon
GRPN
$940M
$521K 0.17%
+22,871
New +$676K
AMST icon
105
Amesite
AMST
$7.01M
$503K 0.16%
+23,350
New +$573K
OVBC icon
106
Ohio Valley Banc Corp
OVBC
$208M
$501K 0.16%
18,358
+15,371
+515% +$400K
AVD icon
107
American Vanguard Corp
AVD
$68.1M
$431K 0.14%
+28,638
New +$453K
SONDW
108
DELISTED
Sonder Holdings Inc Warrants
SONDW
$409K 0.13%
240,287
+25,296
+12% +$37K
AGFS
109
DELISTED
AgroFresh Solutions Inc
AGFS
$368K 0.12%
170,610
+17,115
+11% +$34.6K
OPBK icon
110
OP Bancorp
OPBK
$231M
$334K 0.11%
32,528
+21,449
+194% +$218K
EGO icon
111
Eldorado Gold
EGO
$10.2B
$278K 0.09%
35,898
-130,726
-78% -$1.16M
LUMN icon
112
Lumen
LUMN
$6.91B
$265K 0.09%
21,316
+2,394
+13% +$30K
VEON icon
113
VEON
VEON
$3.94B
$244K 0.08%
4,694
+498
+12% +$23.9K
BSVN icon
114
Bank7 Corp
BSVN
$476M
$206K 0.07%
9,577
+137
+1% +$2.8K
BWEN icon
115
Broadwind
BWEN
$103M
$127K 0.04%
49,174
-297,513
-86% -$1.04M
GSV
116
DELISTED
Gold Standard Ventures Corp.
GSV
$114K 0.04%
250,675
-184,032
-42% -$93.3K
CBFV icon
117
CB Financial Services
CBFV
$189M
$96K 0.03%
4,140
+53
+1% +$1.22K
OVLY icon
118
Oak Valley Bancorp
OVLY
$278M
$95K 0.03%
5,329
+68
+1% +$1.2K
LFLYW
119
DELISTED
Leafly Holdings, Inc. Warrant
LFLYW
$12K ﹤0.01%
+9,927
New +$11.3K
ARKG icon
120
PUT
ARK Genomic Revolution ETF
ARKG
$1.78B
-8,000
Closed -$740K
ARKW icon
121
PUT
ARK Web x.0 ETF
ARKW
$1.76B
-5,700
Closed -$878K
ARRY icon
122
Array Technologies
ARRY
$827M
-55,595
Closed -$867K
CVSA
123
Covista Inc
CVSA
$4.57B
-35,562
Closed -$1.27M
C icon
124
Citigroup
C
$227B
-14,108
Closed -$998K
CMTL icon
125
Comtech Telecommunications
CMTL
$51.5M
-39,405
Closed -$952K

Similar funds

Invenomic Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Invenomic Capital Management held 155 positions worth $308M, down 26% from $418M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Invenomic Capital Management withdrew a net $101M in Q3 2021, closing 36 positions and reducing 13 holdings. Its most notable exit was Lockheed Martin, an estimated $3.38M position sold in full.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 9.1% a quarter earlier, followed by Consumer Discretionary and Materials.

Against the trend, Invenomic Capital Management opened a new position in Alibaba worth $4.31M.

  • Invenomic Capital Management's largest Q3 2021 buy was Alibaba: 29,138 shares worth $4.31M.
  • Invenomic Capital Management added most to Immersion in Q3 2021, an estimated $4.97M increase.
  • Invenomic Capital Management's biggest Q3 2021 reduction was Teck Resources, cutting an estimated $3.41M.
  • Invenomic Capital Management fully exited Lockheed Martin in Q3 2021, selling an estimated $3.38M.
  • Invenomic Capital Management's ten largest holdings make up 28% of its $308M portfolio in Q3 2021.
  • Invenomic Capital Management opened 31 new positions and closed 36 in Q3 2021.
  • Invenomic Capital Management's portfolio value fell 26% quarter-over-quarter to $308M.

Based on Invenomic Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.